HER2 targeting transmembrane therapeutic peptides (PeptiMimesis)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameHER2 targeting transmembrane therapeutic peptides (PeptiMimesis)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Recombinant polypeptide

Mechanisms of ActionReceptor protein-tyrosine kinase erbB-2 modulators

TargetsReceptor protein-tyrosine kinase erbB-2

Therapy Area/IndicationsBrain Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesPeptiMimesis

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPeptiMimesis

Active IndicationsN/A

Inactive IndicationsBrain Neoplasms

ATC CodeN/A